Identifying apicoplast‐targeting antimalarials using high‐throughput compatible approaches
Open Access
- 11 July 2011
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 25 (10) , 3583-3593
Abstract
Malarial parasites have evolved resistance to all previously used therapies, and recent evidence suggests emerging resistance to the first‐line artemisinins. To identify antimalarials with novel mechanisms of action, we have developed a high‐throughput screen targeting the apicoplast organelle of Plasmodium falciparum. Antibiotics known to interfere with this organelle, such as azithromycin, exhibit an unusual phenotype whereby the progeny of drug‐treated parasites die. Our screen exploits this phenomenon by assaying for “delayed death” compounds that exhibit a higher potency after two cycles of intraerythrocytic development compared to one. We report a primary assay employing parasites with an integrated copy of a firefly luciferase reporter gene and a secondary flow cytometry‐based assay using a nucleic acid stain paired with a mitochondrial vital dye. Screening of the U.S. National Institutes of Health Clinical Collection identified known and novel antimalarials including kitasamycin. This inexpensive macrolide, used for agricultural applications, exhibited an in vitro IC 50 in the 50 nM range, comparable to the 30 nM activity of our control drug, azithromycin. Imaging and pharmacologic studies confirmed kitasamycin action against the apicoplast, and in vivo activity was observed in a murine malaria model. These assays provide the foundation for high‐throughput campaigns to identify novel chemotypes for combination therapies to treat multidrug‐resistant malaria.—Ekland, E. H., Schneider, J., Fidock, D. A. Identifying apicoplast‐targeting antimalarials using high‐throughput compatible approaches. FASEB J. 25, 3583–3593 (2011). www.fasebj.orgKeywords
Funding Information
- National Institutes of Health (R21 NS059500)
This publication has 56 references indexed in Scilit:
- Chemical genetics of Plasmodium falciparumNature, 2010
- A var gene promoter implicated in severe malaria nucleates silencing and is regulated by 3′ untranslated region and intronic cis-elementsInternational Journal for Parasitology, 2009
- Artemisinin-based combination therapies: a vital tool in efforts to eliminate malariaNature Reviews Microbiology, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- The evolution of drug-resistant malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Apicoplast translation, transcription and genome replication: targets for antimalarial antibioticsTrends in Parasitology, 2008
- In vitro evaluations of antimalarial drugs and their relevance to clinical outcomesInternational Journal for Parasitology, 2008
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences, 2006
- Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integraseNature Methods, 2006